NXLNasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Nexalin Technology, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 12, 2026
$2.36+0.01 (+0.43%)
Close on Oct 19, 2026
- Market cap
- $49.90M
- P/E (TTM)
- –
- Dividend yield
- –
Ownership
Who owns Nexalin Technology's shares
Held by institutions
–
Shares held, 13F filers
Institutional holders
–
Net institutional buying
–
Insider trades, 12 months
0 buys · 0 sales
Open-market trades only
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Alumni Capital LP | 2,493,075 | 9.99% | 13G (passive) | Aug 19, 2026 |
| Greenlight Ventures, LLC | 1,385,246 | 5.60% | 13D (active) | Aug 18, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Mark White | CEO, Director | 309,127 | 1.40% | Dec 23, 2025 |
| David Owens | Chief Medical Officer, Director | 191,252 | 0.87% | Dec 23, 2025 |
| Carolyn Hamby Shelton | Sr. VP - Quality - Regulatory | 54,000 | 0.25% | Dec 23, 2025 |
| Fleet Justin Van | CFO | 25,000 | 0.11% | Dec 23, 2025 |
| Alan Kazden | Director | 119,590 | 0.54% | Dec 23, 2025 |
| Ben Hu | Director | 381,261 | 1.73% | Dec 23, 2025 |
| Leonard Osser | 10% owner | 2,453,821 | 11.14% | Sep 30, 2025 |
| Marilyn Elson | – | 1,535,244 | 6.97% | Sep 30, 2025 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Alan Kazden Director | Sep 29, 2025 | Award | +36,459 | – | – | 119,590 |
| David Owens Chief Medical Officer, Director | Sep 29, 2025 | Award | +36,459 | – | – | 191,252 |
| Leonard Osser 10% owner | Sep 29, 2025 | Award | +83,333 | – | – | 1,618,577 |
| Ben Hu Director | Sep 29, 2025 | Award | +36,459 | – | – | 377,095 |
| Carolyn Hamby Shelton Sr. VP - Quality, Regulatory | Mar 12, 2025 | Buy | +6,000 | $2.20 | $13.20K | 30,000 |
| David Owens Chief Medical Officer, Director | Feb 4, 2025 | Buy | +1,000 | $3.10 | $3.10K | 155,793 |
| David Owens Chief Medical Officer, Director | Feb 4, 2025 | Buy | +1,000 | $2.98 | $2.98K | 154,793 |
| David Owens Chief Medical Officer, Director | Jan 28, 2025 | Buy | +1,500 | $2.70 | $4.05K | 153,793 |
| David Owens Chief Medical Officer, Director | Jan 23, 2025 | Buy | +1,000 | $2.70 | $2.70K | 152,293 |
| David Owens Chief Medical Officer, Director | Jan 13, 2025 | Buy | +2,000 | $2.50 | $5.00K | 151,293 |
| David Owens Chief Medical Officer, Director | Dec 20, 2024 | Buy | +1,000 | $2.75 | $2.75K | 149,293 |
| David Owens Chief Medical Officer, Director | Oct 28, 2024 | Buy | +500 | $2.19 | $1.10K | 148,293 |
| Carolyn Hamby Shelton Senior VP | Oct 14, 2024 | Buy | +24,000 | $0.85 | $20.40K | 24,000 |
| Ben Hu Director | Sep 30, 2024 | Award | +175,000 | – | – | 340,636 |
| Marilyn Elson 10% owner | Sep 30, 2024 | Award | +700,000 | – | – | 1,535,244 |
| Leslie Bernhard Director | Sep 30, 2024 | Award | +49,838 | – | – | 49,838 |
| Leonard Osser – | Sep 23, 2024 | Award | +700,000 | – | – | 1,535,244 |
| David Owens Chief Medical Officer, Director | Aug 13, 2024 | Buy | +1,000 | $0.95 | $950 | 147,793 |
| David Owens Chief Medical Officer, Director | Jun 28, 2024 | Buy | +1,000 | $1.75 | $1.75K | 146,793 |
| David Owens Chief Medical Officer, Director | Jun 18, 2024 | Buy | +1,619 | $0.71 | $1.15K | 145,793 |
| David Owens Chief Medical Officer, Director | Jun 10, 2024 | Buy | +1,000 | $0.62 | $620 | 144,174 |
| David Owens Chief Medical Officer, Director | Jun 10, 2024 | Buy | +2,000 | $0.65 | $1.30K | 143,174 |
| Leonard Osser – | Sep 28, 2022 | Buy | +9,500 | $1.12 | $10.64K | 835,244 |
| Alan Kazden Director | Sep 16, 2022 | Buy | +2,500 | $4.15 | $10.38K | 83,131 |
| Rick Morad Director | Sep 16, 2022 | Buy | +2,500 | $4.15 | $10.38K | 108,341 |
| Alan Kazden Director | Sep 16, 2022 | Buy | +2,500 | $4.15 | $10.38K | 89,131 |
| Rick Morad Director | Sep 16, 2022 | Buy | +2,500 | $4.15 | $10.38K | 107,989 |
| Leonard Osser – | Sep 16, 2022 | Buy | +36,000 | $4.15 | $149.40K | 825,744 |
| David Owens Chief Medical Officer, Director | Sep 16, 2022 | Buy | +2,500 | $4.15 | $10.38K | 141,174 |
| Mark White President/CEO, Director | Sep 16, 2022 | Buy | +2,500 | $4.15 | $10.38K | 289,627 |
| Mark White President/CEO, Director | Sep 15, 2022 | Buy | +25,000 | $4.15 | $103.75K | 309,127 |
| Mark White President/CEO, Director | Sep 15, 2022 | Buy | +25,000 | $4.15 | $103.75K | 289,627 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Planned insider sales
Notices of proposed sale filed on Form 144 before shares are sold
| Seller | Filed | Shares | Market value | Planned sale | Acquired through |
|---|---|---|---|---|---|
| Marilyn Elson Associate to Affiliate | Sep 10, 2025 | 23,150 | $403 | Sep 10, 2025 | Open Market Purchase |